Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin in Small Cell Lung Cancer
NCT00717938Phase 3Completed
- Sponsor
- Skåne University Hospital
- Start
- Jun 2008
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in small cell lung cancer (SCLC), sponsored by Skåne University Hospital. Started Jun 2008; status: completed.
02
Drugs
enoxaparin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00717938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717938.